Cytonics

No VC. No Strings. No Compromise.

Venture Capital is the kiss of death for biotech.

They swoop in with fat checks, then slowly strangle the company—loading it with liquidation preferences, board control, and demands that serve their fund, not the mission. The result? Innovation gets boxed in. Shareholders get diluted. And the science bends to Wall Street’s quarterly whims.

That’s not us.

Cytonics has never taken a single dime of venture capital—and we never will. We’ve raised over $25 million entirely from individuals like you. People who actually care about building something real, not about hitting an artificial exit timeline.

Equity crowdfunding flips the script:

• Alignment of interests – no VC middlemen skimming value before anyone else.
  
• Democratization – everyday investors get access to deals historically reserved for insiders.
  
• Grassroots power – over 7,000 shareholders strong, united in funding the future of joint health.
  

This isn’t “pay-to-play biotech.” This is biotech funded by the people, for the people.

And it’s working. Every milestone we’ve hit—our patents, our clinical trial progress, our transition to a true clinical-stage biotech—was fueled by the collective power of our community. Not a single venture firm.

Venture capital destroys companies. Crowdfunding builds them.

That’s why Cytonics is still ours.

And yours.

Appreciatively,

Joey Bose

President & CEO